Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pfizer claims glycogen phosphorylase inhibitors

Feb. 4, 1997

Successful completion of phase I trial of aerosolized osteoporosis product

Feb. 3, 1997

Inhale/Lilly collaborate on pulmonary delivery of osteoporosis Rx

Feb. 3, 1997

Hypoglycemic/hypolipidemic agents from Sumitomo Metal

Feb. 3, 1997

Japanese researchers describe compounds for lipoprotein disorders

Feb. 3, 1997

FDA approves Teva drug

Jan. 31, 1997

FDA approves antidiabetic drug within 6 months of filing

Jan. 31, 1997

Biotech launches Diab II

Jan. 31, 1997

Shaman describes antidiabetic agents from natural source

Jan. 31, 1997

Takeda researches follow-up compounds to leuprorelin

Jan. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...